Handelsavisen
prelaunch
Companies Healthcare 7840.T
78
7840.T Tokyo Stock Exchange Medical Equipment, Supplies & Distribution

7840.T

¥1 250,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
41,7B JPY
P/E
EV / Rev
Div yield
3,14 %
Op margin
7,7 %
ROE
7,3 %
Net margin
4,9 %
Debt / equity
0,42
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, providing medical equipment, supplies, and distribution services.

Business. 7840.T is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
7,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 7840.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 7840.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    7840.T is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Specific details regarding its operating segments, headquarters location, and primary stock exchange listing are not provided in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company maintains a balanced capital structure with a debt-to-equity ratio of 0.42, indicating a moderate reliance on debt financing. Its liquidity position is characterized by a current ratio of 2.48, suggesting the company can meet its short-term obligations comfortably. However, the company has negative net cash after subtracting total debt, which may pose a liquidity risk.

    Profitability metrics show a return on equity (ROE) of 7.26% and a return on assets (ROA) of 4.16%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming in terms of capital efficiency and asset utilization compared to its peers. The gross profit margin is 54.56%, which is in line with the industry median, but the operating margin of 7.69% is below the median, suggesting inefficiencies in operating costs.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's revenue is entirely derived from its core operations in the healthcare services and equipment industry.

    Looking ahead, the company is projected to experience a modest growth in revenue, with a year-over-year increase of approximately 2.5% in the current fiscal year. This growth is expected to continue into the next fiscal year, albeit at a slightly slower pace. The company's capital expenditure is negative, indicating a reduction in investment in physical assets, which may affect long-term growth potential.

    The company faces a medium liquidity risk due to its negative net cash position and a moderate debt load. The risk assessment also indicates a low dilution risk, as the number of shares outstanding has remained stable. However, the company's operating cash flow of 7.45 billion JPY is insufficient to cover its long-term debt, which could necessitate future financing activities.

    Recent filings and transcripts indicate that the company is focusing on cost optimization and improving operational efficiency. The company has also been exploring new market opportunities to diversify its revenue streams. These strategic initiatives are aimed at enhancing profitability and reducing dependency on a single business segment.

    Key takeaways
    • The company has a moderate debt load and a balanced capital structure, but its liquidity position is constrained by negative net cash.
    • Profitability metrics are below industry medians, indicating inefficiencies in capital and asset utilization.
    • The company's revenue is concentrated in a single business segment with no geographic diversification, increasing exposure to regional risks.
    • The company is projected to experience modest revenue growth, but its capital expenditure is negative, which may affect long-term growth.
    • The company faces a medium liquidity risk and is exploring cost optimization and market diversification to enhance profitability.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥1 250,00
    Market cap
    ¥40.65B
    Enterprise value
    ¥50.63B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    6.8x
    P / B
    1.0x
    P / Tangible book
    1.0x
    Tangible book
    ¥40.61B
    Net cash
    -¥9.98B
    Current ratio
    2.5
    Debt / equity
    0.4
    ROA
    4.2%
    ROE
    7.3%
    Cash conversion
    253.0%
    CapEx / revenue
    -8.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin7,7 %Above median
    Net Margin4,9 %Above median
    ROE7,3 %Above median
    Capex / Rev-8,2 %Below median
    D/E0,42Below median
    Cash Conv2,53Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • 7840.T Market data — financials · 2026-05-27
    • France Bed Holdings Co Ltd Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    7840.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage